Clinical trials
Trials in Puerto Rico with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Puerto Rico | 9 |
| Auxilio Mutuo Cancer Center | 8 |
| GeneOne Life Science, Inc. | 2 |
| NSABP Foundation Inc | 2 |
| Puerto Rico Community Network for Clinical Research on AIDS | 2 |
| Santaris Pharma A/S | 2 |
| Triangle Pharmaceuticals | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Axcella Health, Inc | 1 |
| Fundacion de Investigacion Science and Education | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 6 |
| HIV Infections | 6 |
| Acquired Immunodeficiency Syndrome | 4 |
| Burkitt Lymphoma | 3 |
| Hepatitis C, Chronic | 3 |
| Lymphoma | 3 |
| Lymphoma, Follicular | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Breast Neoplasms | 2 |
Trials
Showing 51 to 52 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.